The observed upregulation of PGC-1α and OXPHOS post-ADT (Fig. 1E) suggests that ADT may drive prostate cancer cells toward a metabolic reliance on OXPHOS, facilitating progression toward the SCN state. This evidence concerns the gene PPARGC1A and prostate carcinoma.